Navigation Links
Mild Depression may guard aged women

rmful as previously believed. In fact, Blazer added, this group of women probably reflects an average range of emotion. "Maybe this spectrum of moods is more the norm," he said.

Blazer said it's unrealistic to expect individuals to always feel happy, "like you should be popping out of bed with a big smile on your face." Dolores Gallagher-Thompson, a research psychologist at Stanford University School of Medicine in Stanford, Calif., and a member of the American Psychology Association, told UPI although she is unfamiliar with the study, she is familiar with Blazer's provocative research that encourages people to reevaluate how they perceive depression and depression's effects.

The problem with depression in the elderly is that sometimes people become depressed by the regressive health problems that accompany old age and sometimes depression itself can contribute to these ailments. Gallagher-Thompson said that depression has been called the common cold of geriatric mental health.


'"/>




Page: 1 2

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Depression may cause delayed wound healing
3. Diabetes and Depression often go hand-in-hand
4. Depression and heart failure
5. Depression disturbs heart rate
6. Depression a possible danger in elderly
7. Depression linked to mortality
8. Depression increases heart attacks
9. More People Seeking Treatment for Depression
10. Depression elevates heart failure risk
11. Depression hurts the heart
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mild Depression may guard aged women

(Date:7/25/2008)... This donation will be used to facilitate...ices for children , Haupp...ivci.com ), a leading integrator of enterprise co...deo conferencing, telepresence, audio visual integ...ed today that it has donated video conferencing eq...
(Date:7/24/2008)...EM, N.C. Researchers at Wake Forest University B...ng clinical belief that the hepatitis C virus slow... itself after HIV patients are treated with a comb...atitis C (HCV) infection is more serious in HIV-in...rding to the Centers for Disease Control. Intraven...
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Speaker Nancy P...g in support of the Tom Lantos,and Henry J. Hyde G...nd,Malaria Reauthorization Act of 2008. The bill, ...e this evening by a vote of 303 to 115 and will no...Today the House took an historic vote to pass land...
(Date:7/24/2008)...olo., July 24 /PRNewswire/ -- An Arapahoe County D...ic company what will likely,amount to more than $1...tween the minority shareholders of Inverness-based...-based private company PR Pharmaceuticals, Inc.,Th...dent, Steven Howe, and,CEO, Dr. Patrick Bols, brea...
Breaking Medicine News(10 mins):Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2Health News:Jury Award to Englewood Company to Total More Than $1 Million for Breach of Fiduciary Duties in Shareholder Class Action Case 2
...er Christina Aguilera is fuelling her pregnancy ru.... The 26-year-old is reportedly pregnant with hub...following her visit to maternity doctor recently. ...s also denied confirming the reports. 'I cannot c...
...bureaucratic reaction, the Californian authorities...ital at the centre of national outrage over a wom...cy room. The Martin Luther King Jr.-Harbor hospi...unty department of Health Services, is located n...
...some positive effects as well, for researchers hav...oid arthritis . The study was conducted by a team... Stockholm, Sweden. As part of the study, researc...tion-based case-control study of incident cases of...
...the University of Pittsburgh School of Medicine ha...ave significant implications for the treatment of ...om muscle-derived stem cells (MDSCs) and a biodegr... extensive remodelling, and remain free of blockag...
Other Medicine News:Health News:Government Mulls Closure of Hospital Where a Woman Died Unattended in ER 2Health News:Government Mulls Closure of Hospital Where a Woman Died Unattended in ER 3Health News:Government Mulls Closure of Hospital Where a Woman Died Unattended in ER 4Health News:Alcohol Consumption may Help to Protect Against Rheumatoid Arthritis 2Health News:Scientists Develop Artificial Blood Vessels for Vascular Grafts in Mice 2
(Date:7/22/2008)...cuss Development Plan Completed Successfully, DUB...arin Corporation,plc (NASDAQ: AMRN ) today announ...t the U.S. Food and Drug Administration (FDA) to d...he treatment of,hypertriglyceridemia. Following th...e 3 with AMR101 in hypertriglyceridemia., Dr. Dec...
(Date:7/22/2008)...l Stress the Importance to Patients of Passing a ...ay, RICHMOND, Va., July 22 /PRNewswire-FirstCall/...ollow-on biologics and biopharmaceuticals, today,a..., will present at a,Congressional briefing on Frid...d for establishing an approval pathway for follow-...
(Date:7/22/2008)...ative Laser Lipolysis Technology in the European ...ass., July 22 /- Cynosure, ...ufacturer of a broad array of,light-based aestheti...Mark,for Smartlipo MPX(TM), the company,s high-pow...uefy fat and tighten skin through collagen,remodel...
(Date:7/21/2008)...s on use of Zevalin as consolidation therapy after...ents with follicular ...l/ -- Cell Therapeutics, Inc.,(CTI) (Nasdaq and MT...duled,a meeting with the U.S. Food and Drug Admini...lity of filing a supplemental Biologics License,Ap...
Breaking Medicine Technology:Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4Halozyme Therapeutics Presents Pre Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association 1791 1Halozyme Therapeutics Presents Pre Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association 1791 2Halozyme Therapeutics Presents Pre Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association 1791 3Halozyme Therapeutics Presents Pre Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association 1791 4New HPV Vaccine Promising in Mice 16809 1New HPV Vaccine Promising in Mice 16809 2New HPV Vaccine Promising in Mice 16809 3Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 1Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 2Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 3Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 4Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 5Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 6Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 7Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 8Forest Laboratories Inc Reports Fiscal Year 2008 Fourth Quarter Reported EPS of 240 55 Including 240 35 Per Share Charge for Licensing Payment 16804 9AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4593 1AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4593 2AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4593 3AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4593 4
...e People with Diabetes, Hospital,and Professional ...PITTSBURGH, April 02, 2007 /PRNewswire-FirstCall/ ...announced today the,release of a new report on the...with Type 2 diabetes. The inaugural Pittsburgh Typ...of patient,demographics, hospital and professional...
...archers report that a,variation in a portion of DN...this common variation may be responsible for up to...in the United States.,The research was conducted b... (NCI), part of the National Institutes of Health,...of Susceptibility,(CGEMS) initiative. CGEMS resear...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 2Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 3Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 4
Straight shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish.
Straight shafts with teeth and 6 mm crisscross serrated tying surfaces. Serrated handle with polished finish.
Straight shafts with 1 x 2 teeth. Wide serrated handle with polished finish.
Serrated, 10 mm tips angled 90 degrees. Serrated cross action handle with polished finish.
Medicine Products: